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This perspective article provides observations supporting the view that nigro-striatal
dopamine neurons and meso-limbic dopamine neurons mainly communicate through
short distance volume transmission in the um range with dopamine diffusing into
extrasynaptic and synaptic regions of glutamate and GABA synapses. Based on this
communication it is discussed how volume transmission modulates synaptic glutamate
transmission onto the D1R modulated direct and D2R modulated indirect GABA
pathways of the dorsal striatum. Each nigro-striatal dopamine neuron was first calculated
to form large numbers of neostriatal DA nerve terminals and then found to give rise
to dense axonal arborizations spread over the neostriatum, from which dopamine is
released. These neurons can through DA volume transmission directly influence not
only the striatal GABA projection neurons but all the striatal cell types in parallel.
It includes the GABA nerve cells forming the island-/striosome GABA pathway to
the nigral dopamine cells, the striatal cholinergic interneurons and the striatal GABA
interneurons. The dopamine modulation of the different striatal nerve cell types involves
the five dopamine receptor subtypes, D1R to D5R receptors, and their formation of
multiple extrasynaptic and synaptic dopamine homo and heteroreceptor complexes.
These features of the nigro-striatal dopamine neuron to modulate in parallel the
activity of practically all the striatal nerve cell types in the dorsal striatum, through
the dopamine receptor complexes allows us to understand its unique and crucial
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fine-tuning of movements, which is lost in Parkinson’s disease. Integration of striatal
dopamine signals with other transmitter systems in the striatum mainly takes place
via the receptor-receptor interactions in dopamine heteroreceptor complexes. Such
molecular events also participate in the integration of volume transmission and
synaptic transmission. Dopamine modulation of the glutamate synapses on the
dorsal striato-pallidal GABA pathway involves D2R heteroreceptor complexes such as
D2R-NMDAR, A2AR-D2R, and NTSR1-D2R heteroreceptor complexes. The dopamine
modulation of glutamate synapses on the striato-entopeduncular/nigral pathway takes
place mainly via D1R heteroreceptor complexes such as D1R-NMDAR, A2R-D1R, and
D1R-D3R heteroreceptor complexes. Dopamine modulation of the island/striosome
compartment of the dorsal striatum projecting to the nigral dopamine cells involve
D4R-MOR heteroreceptor complexes. All these receptor-receptor interactions have
relevance for Parkinson’s disease and its treatment.
Keywords: G protein-coupled receptor, dopamine receptor, heteroreceptor complexes, oligomerization,
Parkinson’s diseases, volume transmission, neural plasticity
INTRODUCTION
A major step in understanding the role of dopamine (DA)
in the brain (Carlsson and Waldeck, 1958) was the discovery
that DA exists in a number of central DA neuron systems
(Fuxe, 1963, 1965a,b; Anden et al., 1964, 1966; Dahlstroem
and Fuxe, 1964; Fuxe et al., 1970a). They were demonstrated
using the Falck Hillarp histochemical fluorescence method
for DA, noradrenaline (NA), and serotonin (5-HT) (Falck
and Torp, 1962; Fuxe and Jonsson, 1973). DA was visualized
through a reaction with formaldehyde which involved a
condensation followed by a dehydrogenation yielding a 3,4-
dihydroisoquinoline. Its quinoidal form was the fluorophor,
which when excited, gave the green fluorescence emission at
480 nm. Quantitation of the Falck-Hillarp method was also made
(Agnati et al., 1979; Andersson et al., 1985).
The first DA neuron system to be identified was the tubero-
infundibular DA system with arcuate DA cell bodies innervating
the external layer of the median eminence (Fuxe, 1963; Fuxe
et al., 1964) and releasing DA into the portal vessels as a prolactin
inhibitory factor (Fuxe et al., 2007b).
Then the nigro-striatal DA neurons were found to densely
and diffusely innervate the neostriatum (dorsal striatum) and to
likely degenerate in Parkinson’s disease (Dahlstroem and Fuxe,
1964; Fuxe, 1965a,b; Ungerstedt, 1971). The islandic (striosomal)
component of the neostriatal DA innervation was observed
in 1970–1972 giving the first evidence for the organization of
the dorsal striatum into two components (Olson et al., 1972;
Tennyson et al., 1972). The nigro-striatal DA system consists
of around 20,000 nerve cells in the rat (German and Manaye,
1993; Aguirre et al., 1999). It was calculated that each nigro-
striatal DA neuron can form large numbers of axonal terminals
in the neostriatum with the total length varying from 55 to 77 cm
characterized by highly dense axonal arborizations widely spread
in the neostriatum (Anden et al., 1966; Matsuda et al., 2009).
The meso-limbic DA neurons were discovered at the same
time as the nigro-striatal DA neurons. The DA cell bodies were
found in the ventral tegmental area and innervated subcortical
limbic regions, especially the nucleus accumbens and olfactory
tubercle of the ventral striatum (Dahlstroem and Fuxe, 1964;
Fuxe, 1965a,b).
Pharmacological work in this period by Carlsson and
Lindqvist (1963) indicated that antipsychotic drugs may act by
blocking DA receptors, supported by the work of Anden et al.
(1970). Later on they were shown to be of the D2 receptor type
(D2R) (Seeman, 1987). It was proposed that DA receptors of
the meso-limbic DA neurons can be one major target for anti-
psychotic drugs (Fuxe et al., 1970b). The cortical component of
the meso-limbic DA neurons was discovered in 1973 (Thierry
et al., 1973) with DA nerve terminals innervating especially the
prefrontal cortex in low to moderate densities (Berger et al.,
1976). Evidence was already obtained in 1970 that the meso-
limbic DA neurons may be reward neurons (Arbuthnott et al.,
1970). Thus, electrical stimulation of the ventral tegmental
area (VTA) DA neurons using the protocol for electrical self-
stimulation resulted in increased DA turnover in the nucleus
accumbens shown with the tyrosine hydroxylase inhibition
method (Arbuthnott et al., 1970).
It should be underlined that the mapping out of the above
DA neurons and other types of DA neurons in the CNS was
validated with immunohistochemistry by means of antibodies
against L-dopa decarboxylase and tyrosine hydroxylase through a
close collaboration with Dr. Menek Goldstein (Fuxe et al., 1978b;
Goldstein et al., 1978). This was of importance since several
groups challenged the existence of the DA pathways, which had
been demonstrated with the Falck-Hillarp technique in the thesis
by Fuxe in 1965.
Through a collaboration with Prof. Paul Manger who played a
leading role in this work, observations across many mammalian
species (over 40 species studied) supported the view that the DA
pathways in the laboratory rat are very similar to that found in
other rodents (Bhagwandin et al., 2008; Limacher et al., 2008;
Kruger et al., 2012; Calvey et al., 2015, 2016). They are broadly
similar in other mammalian orders as studied with tyrosine
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hydroxylase immunohistochemistry. There appeared to exist a
phylogenetic constraint preventing alterations in the parcellation
of the DA cell groups within species belonging to the same
mammalian order (Manger, 2005; Dell et al., 2010). Major
variations are only observed when comparing species between
different mammalian orders (Manger et al., 2004; Maseko et al.,
2013). The only exception was found in the brain of the bottle
nose dolphin (Manger et al., 2004). Thus, within the same
mammalian order the same complement of monoamine cell
groups exists within the DA, NA, and 5-HT neuron systems
irrespective of changes in features such as brain mass, life history
or adult phenotype (Manger, 2005; Bhagwandin et al., 2008;
Limacher et al., 2008; Dell et al., 2010; Kruger et al., 2012; Calvey
et al., 2015).
This perspective article will provide observations supporting
the view that nigro-striatal DA neurons mainly communicate via
volume transmission (Fuxe et al., 2013b; Borroto-Escuela et al.,
2015a). Based on this communication it will be discussed how
volume transmission modulates synaptic glutamate transmission
onto the D1R modulated direct and D2R modulated indirect
GABA pathways of the dorsal striatum. Likewise, in the ventral
striatum the meso-limbic DA neurons instead modulate via
volume transmission the D1R regulated accumbens GABA
reward neurons and D2R regulated accumbens GABA anti-
reward neurons, known as the ventral striato-pallidal GABA
pathway. The major molecular mechanism involved appears
to be the formation of DA heteroreceptor complexes (Fuxe
et al., 2014b,d; Borroto-Escuela et al., 2016b; Borroto-Escuela
and Fuxe, 2017) in glutamate synapses and their extrasynaptic
membranes components. In synaptic heteroreceptor complexes
volume transmission and synaptic transmission can become
integrated.
VOLUME TRANSMISSION IN BRAIN DA
NEURONS
Early on with the discovery and characterization of the
brainstem monoamine neurons and their pathways it became
clear that their massive collaterals, built up of varicose nerve
terminals, to a varying degree globally innervated the brain and
the spinal cord (Fuxe, 1965a,b; Fuxe and Dahlstrom, 2009).
The impression obtained from the chemical neuroanatomical
analysis was that the monoamine neurons did not operate via
synaptic transmission but modulated the excitatory glutamate
and inhibitory GABA synapses of the CNS belonging to the
glutamate projection neurons and GABA projection neurons
and interneurons. In line with this impression was the existence
of the adrenergic ground plexus of varicose terminals in the
peripheral nervous systemwhich had a resemblance to the central
catecholamine networks of varicose terminals. It should be noted
that the peripheral varicose adrenergic nerve terminals of the
ground plexus lacked synapses with release of NA into the
extracellular fluids (ECF) (Malmfors, 1965).
It was also found that DA can diffuse in the brain
(Ungerstedt et al., 1969) and amphetamine produced a diffuse
DA fluorescence around the midbrain DA cell bodies after
monoamine oxidase inhibition likely due to DA release into
the extracellular fluid (Fuxe et al., 1970a,c). Non-junctional 5-
HT varicosities were found in 1975 (Descarries et al., 1975)
and transmitter-receptor mismatches in the opioid peptide
systems in 1986 (Agnati et al., 1986). As a result the concept
of volume transmission was introduced representing a major
communication in the CNS taking place in ECF and cerebro-
spinal fluid (CSF) and thus in the extracellular space and
the ventricular system, respectively (Agnati et al., 1986; Fuxe
et al., 1988; MacMillan et al., 1998). Several types of volume
transmission exist: rapid extrasynaptic volume transmission (100
msec-sec), slow long-distance volume transmission in ECF and
CSF (s-h), and microvesicle- mediated volume transmission
(MacMillan et al., 1998; Agnati and Fuxe, 2000; Fuxe et al.,
2007b, 2010a, 2013a,b, 2015a; Agnati et al., 2010; Borroto-
Escuela et al., 2013e, 2015a; Fuxe and Borroto-Escuela, 2016b).
All cells in the CNS can communicate via volume transmission
including also glial cells, pericytes and endothelial cells, which
only communicate via this mode of transmission (Fuxe et al.,
2015a).
Extrasynaptic volume transmission may be the major mode of
communication of DA neurons and other types of monoamine
neurons (Fuxe et al., 2007b, 2010a). In many cases the DA
nerve terminal varicosities are asynaptic and release DA into
the extracellular space without forming synapses to activate
extrasynaptic and synaptic DA receptors around and within
glutamate and GABA synapses via short distance diffusion. Also
DA receptors on glial cells can be reached and become activated
(Carmignoto, 2000; Fuxe et al., 2015a).
In line with this view non-junctional DA varicosities were
present in high numbers in the dorsal striatum (Descarries et al.,
1996). The D1R and D2R immunoreactivities was mainly located
outside the DA synapses, when formed, close to the glutamate
synapses as well as the GABA synapses as demonstrated with
electronmicroscopic immunohistochemistry (Levey et al., 1993;
Sesack et al., 1994; Smiley et al., 1994). These findings strongly
support our hypothesis that volume transmission is the major
mode of communication in the DA neurons. It should be noted
that the DA varicosities which are synaptic co-localize with
vesicular glutamate transporter 2 (Descarries et al., 2008). Thus,
there is the possibility that the potential of DA axon terminals to
release glutamate is linked to the formation synaptic junctions.
A major contribution was made by Rice and Cragg (2008)
who modeled DA spillover after quantal release based on a large
number of experimental findings by many groups in the DA
field. They concluded that the DA diffusion process was too fast
for the DAT to counteract it and that the major mode of DA
communication was short distance volume transmission, which
can activate high affinity DA receptors within a range of 7–8µm.
This extrasynaptic type of DA volume transmission appears
to exist also in vivo in the human striatum with regard to
D2-like receptors (Drevets et al., 2001). Thus, amphetamine-
induced increases in extracellular DA levels produced substantial
decreases of [11C] raclopride (D2-like radioligand) and [11C]
MNPA (D2-like agonist radioligand) binding in the non-human
dorsal striatum using PET (Seneca et al., 2006). Furthermore, the
KiH value for DA at [3H] raclopride-labeled D2-like receptors
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in neostriatum was found to be 12 nM (Marcellino et al., 2012).
Taken together, these findings can be explained by the existence
of D2 like receptor mediated extrasynaptic volume transmission
in the brain in vivo.
Tubero-Infundibular DA Neurons
These DA neurons especially innervate the lateral palisade zone
of the external layer of the median eminence where high densities
of DA terminals exist close to the LHRH immunoreactive
nerve terminals. No synapses exist in this region. Therefore,
dopamine D1Rs and/or dopamine D2Rs found in this region
(Romero-Fernandez et al., 2014) mediate short distance volume
transmission which contributes to the inhibition of luteinizing
hormone releasing hormone release from nerve terminals in
this region (Fuxe et al., 1978c; Andersson et al., 1984; Romero-
Fernandez et al., 2014).
Instead in the medial palisade zone with only low to modest
densities of punctate D1R and D2R immunoreactivies DA is
likely mainly released as a prolactin inhibitory factor into the
hypophyseal portal vessels to activate D2Rs on the prolactin
cells of the anterior pituitary (Fuxe et al., 1967; MacLeod and
Lehmeyer, 1974; Andersson et al., 1981). Thus, in this case DA
operates as a hypothalamic hormone.
Nigro-Striatal DA Neurons
The major communication in these DA neurons is the short
distance extrasynaptic volume transmission in the um range
as discussed above involving all the DA receptor subtypes
from D1 to D5 receptors (Fuxe et al., 2015a). This is true
for the matrix DA nerve terminal networks as well as for the
DA networks of the striosome/island compartment. The major
difference instead exists in the receptor peculiarities of the two
compartments with inter alia an enrichment of the D4Rs and
their D4R heteroreceptor complexes in the striosomal/islandic
compartment (Rivera et al., 2002b, 2017).
However, during the progressive degeneration of the striatal
DA nerve terminal networks in Parkinson’s disease a long
distance form of DA volume transmission develops in the
dorsal striatum from the remaining DA nerve terminals (Fuxe
et al., 1979). There are several mechanisms involved in this
event, namely a compensatory increase of the activity in the
remaining DA neurons, loss of DAT through the DA nerve
terminal degeneration and supersensitivity development in the
DA receptor subtypes. In this way the DA neuromodulation
of the striatal GABA output neurons and interneurons can
be maintained for a long period after disease onset. The
DA volume transmission can be substantially restored by the
levodopa treatment (Carlsson, 2002). Treatment with the DA
receptor agonist apomorphine and D2-like receptor agonists
like bromocryptine can substitute for the loss of DA volume
transmission (Fuxe et al., 2015a,b).
Meso-Limbic DA Neurons
Amygdala
Also in major parts of the nucleus accumbens, olfactory tubercle
and the amygdala the short distance extrasynaptic DA volume
transmission is a dominant communication (Fuxe et al., 2007b).
However, as observed also in D1R mediated transmission and
retinal DA neurons (Fuxe et al., 1988; Bjelke et al., 1996) a
long-distance volume transmission appears to exist in certain
parts of the meso-limbic DA neurons, namely in the most
ventral D1R-rich GABA intercalated masses, the D1R-rich rostro
medial and caudal components of the GABA intercalated mass
of the amygdala (Fuxe et al., 2003b) and in parts of the nucleus
accumbens shell (Jansson et al., 1999). In these regions receptor-
transmitter mismatches were observed.
In most intercalated cell masses and the rostrolateral portion
of the main GABAintercalated cell mass a high density of DA
nerve terminals was found. Thus, here a short distance volume
transmission appeared to exist reaching the high density of D1Rs
in these cells (Fuxe et al., 2003b).
In contrast, in the D1R rich dorsomedial and caudal
components of the main intercalated cell mass only scattered DA
terminals were found which led us to propose that a long distance
D1R mediated volume transmission may be in operation in these
intercalated GABA cell masses (Fuxe et al., 2003b).
D1R agonists are known to produce anxiogenic actions (de
la Mora et al., 2010). This action can involve an inhibition of
the D1R positive lateral paracapsular GABA neurons innervating
glutamate neurons of the basolateral amygdala (BLA) (Marowsky
et al., 2005). These glutamate neurons upon activation causes
feed forward disinhibition of the excitatory neurons of the
medial portion of the central amygdaloid nucleus leading to
an increase in anxiety. However, to reduce fear, a glutamate
projection from the medial prefrontal cortex to the lateral
paracapsular intercalated cell masses can activate their GABA
neurons, leading to inhibition of BLA glutamate neurons. Under
such conditions, disinhibition is blocked and anxiety does not
develop (de la Mora et al., 2010). D1R activation on these
GABA islands can oppose such excitatory effects on the islands
and disinhibition of the glutamate BLA neurons can take place
(Rosenkranz and Grace, 2001, 2002). The molecular mechanism
involved can be the ability of the agonist activated D1R
signaling to open up the G protein coupled inwardly rectifying
potassium channels of the paracapsular GABA neurons leading
to their hyperpolarization and inhibition with the consequent
disinhibition of the glutamate BLA neurons (Marowsky et al.,
2005).
Preferential activation of the D1Rs located on the rostral-
lateral component of the main intercalated GABA island
may take place since unlike the caudal-medial component
this portion of the main intercalated cell mass has a high
density of DA terminals. Furthermore, the caudal-medial
portion is innervated and inhibited by GABA neurons from
the rostral-lateral component. In view of these features
preferential activation of the DA terminal system to the main
intercalated GABA cell mass may contribute to increased
anxiety development. Thus, hyperpolatization should only
develop in the rostral-lateral component. Therefore, activity
is set free in the caudal-medial component of the main
intercalated island innervating the medial subnucleus of
the central amygdala and the outflow of excitatory activity
leading to anxiety is counteracted. An anxiolytic activity
develops.
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It should be noted however that the D1Rs in the caudal-
medial component lacking a clear DA innervation can have a
special meaning. It may be speculated that these intercalated
islands can become activated through long distance DA volume
transmission mainly from the rostral intercalated islands which
are richly innervated by dopamine terminals. The distance of
diffusion/flow is in the range of 25 to 50 um. It is possible
that special pathways for diffusion and flow of DA exists
from the rostral-lateral to the caudal-medial component within
the intercalated GABA cell masses. In this environment the
monoamine oxidase may have a reduced activity and/or DA may
be bound to chaperone molecules. Such events may also take
place in the transport of DA as a prolactin inhibitory factor in
the portal vessels to the anterior pituitary gland.
The functional meaning of this long distance DA volume
transmission can in this case be to restore anxiogenic activity. It
may help survival to rapidly restore fear upon a period in which
it was reduced.
Nucleus Accumbens
A clearcut DA terminal-DA D1R mismatch was observed in
rostro-caudal extending compartments of the nucleus accumbens
shell, rich in D1R immunoreactivity but with few DA terminals
(Jansson et al., 1999). This is of high interest since the D1Rs
exist in reward neurons of the nucleus accumbens, see Kalivas
(2009). This mismatch is in the order of 35 to 50 um and
indicate the existence of long distance volume transmission (see
above). Uncoupling protein 2 (UCP2) was discovered in the
brain (Horvath et al., 1999) and is of high interest for volume
transmission, since it may produce small temperature gradients
in the CNS. It may therefore enhance the flow of volume
transmission signals in extracellular pathways of the CNS. In line
with this view it was found that strong UCP2 immunoreactivity
was found in the DA terminal rich regions surrounding the
D1R rich mismatch area of the nucleus accumbens with few
DA terminals and lacking UCP2 immunoreactivity (Rivera et al.,
2006). The results therefore indicate that the flow of long distance
DA volume transmission can become enhanced in mismatch
regions through temperature gradients produced by UCP2.
It was proposed that the delay of the DA signal to activate
the D1 receptors on reward neurons in the nucleus accumbens
shell can be the mechanism for the ability to predict rewards
in the future (Guidolin et al., 2017). Due to the difference
in speed between long distance DA volume transmission and
extrasynaptic DA volume transmission the activation of the D1R
in the mismatch area is correlated to a previous DA release event
at the DA terminal. A temporal-learning process can therefore
be initiated leading to prediction of reward. These results give an
important meaning to long distance DA volume transmission.
DA Transmission in the Cerebral Cortex
In the rat brain D1R and D2R immunoreactivities are mainly
found in populations of pyramidal neurons, interneurons and
glial cells in the prefrontal and limbic cortices (Smiley et al.,
1994; Fuxe et al., 2007b). D1R, D2R, and D5R mainly exist in
layers V and VI of the cerebral cortex (Vincent et al., 1993; Khan
et al., 2000). Short distance volume transmission appears to be
the major mode of communication.
In contrast, the D4R immunoreactivity is found in many
areas of the cerebral cortex with highest levels in e.g., motor,
somatosensory, cingulate, and retrosplenial cortices (Ariano
et al., 1997; Rivera et al., 2008).
The D4R immunoreactivity is mainly localized to layer II/III
and in the case of visual, auditory and somatosensory cortices
also to Layer IV (Ariano et al., 1997; Rivera et al., 2008). Thus,
bilaminar localization of the D4R immunoreactivity takes place
with D4R expression in both glutamate pyramidal neurons and
GABA interneurons.
It is of high interest that D4Rs have a high affinity also for
NA (Newman-Tancredi et al., 1997). In fact, the global cortical
NA terminal plexus match better the widespread distribution
of the D4R imunoreactive neurons than the DA terminal plexa
mainly found in the prefrontal and limbic cortices (Rivera
et al., 2008). There is a frequent lack of colocalization of D4R
immunoreactive structures and DA and NA terminal networks
giving a significant indication that the short distance DA and NA
volume transmission is used to activate the D4Rs. However, in
layers II/III with the highest density of D4R immunorectivity,
25% of the DA and NA varicosities were in direct contact
with the D4R immunoreactive profiles suggesting synaptic
interaction based on ultrastructural analysis (Rivera et al., 2008).
Furthermore, in this layer the closest catecholamine varicosities
without direct contacts were at a distance of 1µm from the D4R
positive processes, leading to an effective short distance volume
transmission. It should also be consider that dopamine can be
release from noradrenergic nerve terminals as indicated from
studies on the hippocampus (Kempadoo et al., 2016). It should
also be noted that Descarries and colleagues observed a varying
frequency of dopamine synapses forms in the cerebral cortex
when analyzing the anteromedial and the suprarhinal cortex
(Seguela et al., 1988).
Taken together, cortical short distance DA volume
transmission plays a major role in cortical DA transmission
where the D4R is of special significance in view of its
widespread distribution and by being a target also for NA






A new understanding of brain integration at the molecular level
developed in the early 1980’s with the discovery of receptor-
receptor interactions in the plasma membrane (Fuxe et al.,
1983a,b). It was based on observations that neuropeptides could
modulate the affinity and density of monoamine receptors
of membrane preparations from brain regions in a receptor
subtype specific way, see also (Fuxe and Agnati, 1985). It was
proposed that the allosteric receptor-receptor interactions took
place in receptor heterodimers and/or higher order heteromers
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formed from the corresponding receptor homodimers and/or
monomers (Zoli et al., 1993). It gave a new biological principle to
integration of signals in the CNS. Through allosteric mechanisms
the reciprocal receptor-receptor interactions could alter the
signaling, recognition and trafficking as well as the pharmacology
of the participating receptor protomers in a dynamic way. They
became moonlighting proteins that could change the function of
the receptor heteromers (Borroto-Escuela et al., 2011c; Fuxe et al.,
2014c). Novel allosteric binding sites could also develop.
The first evidence for a GPCR-GPCR heteromer came with
the demonstration that the GABAB receptor was a heterodimer
built up of two types of GABA receptor protomers, GABAB1
and GABAB2 (White et al., 1998; Marshall et al., 1999). The
first GPCR-ligand gated ion channel receptor heteromer was
discovered by Fang Liu and colleagues in 2000 (Liu et al., 2000),
built up of GABAA and D5Rs. In line with these results it
was already found in 1997 that the GABAA-dopamine receptor-
receptor interactions exist in striatal membranes (delaMora et al.,
1997). In 2007 the first GPCR-RTK heteromer was identified
formed between A2A and FGFR1 receptors (Flajolet et al., 2008;
Borroto-Escuela et al., 2013b). The same year the D2R was
also found to form a complex with the DA transporter (Lee
et al., 2007). To-day large numbers of GPCR heteromers have
been established using inter alia coimmunoprecipitation, FRET-
BRET, fluorescence complementation techniques, and proximity
ligation assays (Borroto-Escuela et al., 2013b,d, 2014, 2016a).
However, there is a need to understand the molecular
organization of the receptor homomers and heteromers,
especially with regard to the stoichiometry of the participating
receptor protomers and sets of receptor interacting proteins
(adaptor proteins) (Fuxe and Borroto-Escuela, 2016a). For
this reason the heteromers are to-day called heteroreceptor
complexes, since they are not only formed by the GPCR
protomers, but also for multiple interacting proteins (Bockaert
et al., 2003, 2010; Borroto-Escuela et al., 2010a, 2011a, 2012a).
The features of the receptor interface are of particular interest
in order to understand why receptor pairs form or do not form
heteromers. Therefore, models of receptor heterodimers should
be built to characterize the interface at the atomic level. Of
special interest was the introduction of the triplet puzzle theory
(Tarakanov and Fuxe, 2010; Tarakanov et al., 2011, 2012). Using
a mathematical approach it became possible to deduce sets of
triplet amino acid homologies (protriplets) that should be part of
the receptor interface and help guide the receptors toward each
other. The protriplets were found in receptor heteromers but not
in non-heteromers (Tarakanov and Fuxe, 2017).




It was proposed that synaptic and volume transmission in
the CNS mainly become integrated through heteroreceptor
complexes located in synaptic and extrasynaptic membranes
(Fuxe et al., 2013b; Borroto-Escuela et al., 2015a; Fuxe
and Borroto-Escuela, 2016b) (Figures 1–3). Integration at the
molecular level can also take place in the intracellular signaling
pathways which is of special value for integrating signaling from
extrasynaptic and synaptic membrane regions. This often takes
place in dendritic spines.
Our view of the synapse is that the postsynaptic membrane is
built up of multiple homo and heteroreceptor complexes where
the glutamate receptor complexes dominate in the glutamate
synapse and the GABA receptor complexes in the GABA synapse.
In the extrasynaptic regions of the glutamate and GABA synapses
the glutamate and GABA heteroreceptor complexes may be the
major complexes at the nerve terminal and dendrite location in
order to increase integration of signals at the local circuit level. In
this way the glutamate and GABA synaptic signaling will receive
information from other networks involved and the context of the
local neuronal activity in which their work is obtained.
In the postsynaptic membrane ionotropic receptors can
form heteroreceptor complexes with GPCRs, a field pioneered
by Prof. Fang Liu (Liu et al., 2000, 2006; Lee et al., 2002).
Such receptor complexes may regulate synaptic strength via
the agonist activated GPCR protomer which modulates the
amplitude of current flow and/or its frequency in the ion
channel belonging the glutamate or the GABAA receptor
protomer. Activation of the GPCR protomer over time
in such receptor complexes can also produce changes in
synaptic plasticity by altering the balance of the different
homo and heteroreceptor complexes in the postsynaptic
membrane and/or changes in their allosteric receptor-receptor
interactions (Borroto-Escuela et al., 2015b, 2016a, 2017a,b,c;
Feltmann et al., 2018). GPCR-RTK heteroreceptor complexes
including their receptor-receptor interactions can also undergo
dynamic changes in functional states and in diseases (Flajolet
et al., 2008; Borroto-Escuela et al., 2013a,b, 2016c, 2017a).
Several molecular mechanisms can be in operation: changes
in transcription e.g., of adaptor proteins, in internalization
of receptor protomers, conformational changes in receptors
reducing the affinity for each protomer with increased affinity for
other receptors. In this way, the homo and the heteroreceptor
complexes and their allosteric receptor-receptor interaction in
the postsynaptic membrane become altered. This can reflect
a learning process and a short term memory can be formed
in the synapse from this novel receptor assembly, which may
become stabilized into a long-term memory with conserved
allosteric receptor-receptor interactions (molecular engram)
(Fuxe et al., 2014a,b; Borroto-Escuela et al., 2015a, 2016d).
Such dynamic changes in the homo-hetero receptor complexes
likely develop also in the presynaptic membrane to help
stabilize the transmitter release pattern to be learned and in the
extrasynaptic homo-heteroreceptor complexes to give context
information to the memories to be formed in the postsynaptic
membrane.
The formation of heteroreceptor complexes appears to be
a general molecular mechanism for integration of signals in
the neural-glial networks of the CNS (Fuxe et al., 2012).
The DA D1R and D2R are hub receptors (Borroto-Escuela
et al., 2014) by participating in a large number of D1R and
D2R heteroreceptor complexes, the D1R complexes usually
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FIGURE 1 | Illustration of how extrasynaptic dopamine (DA) volume transmission modulates transmission of the striato-pallidal GABA neurons (indirect pathway) and
the striato-entopeduncular/nigral GABA neurons (direct pathway) at their dendritic spines. The extrasynaptic integration of DA and adenosine volume transmission
takes place in the indirect pathway via extrasynaptic A2AR-D2R heteroreceptor complexes shown as heterodimers in balance with extrasynaptic D2R and A2AR
homoreceptor complexes, shown as homodimers. In the direct pathway adenosine and dopamine volume transmission instead becomes integrated in extrasynaptic
A1R-D1R heteroreceptor complexes, shown as heterodimers in balance with extrasynaptic D1R and A1R homoeceptor complexes, shown as homodimers. As to
synaptic transmission in the indirect pathway, the synaptic glutamate transmission and DA volume transmission becomes integrated in D2R-NMDAR heteroreceptor
complexes, shown as a heterodimer, located mainly in the postsynaptic membrane of the glutamate synapse on the dendritic spines of the striato-pallidal GABA
neurons. Instead in the direct pathway the synaptic glutamate transmission and the DA volume transmission becomes integrated in D1R-NMDAR heteroreceptor
complexes, shown as a heterodimer, mainly located on the postsynaptic membrane of the glutamate synapse located on the striato-entopeduncular/nigral GABA
pathway. In the center of the image the DA varicosity is demonstrated to release DA, which via extrasynaptic volume transmission can reach in a similar time-frame the
D2Rs of the indirect GABA pathway and the D1Rs of the direct GABA pathway. In this way an optimal modulation of movements can develop through D2R induced
reduction of the motor brake (indirect pathway) and D1R induced enhancement of motor initiation (direct pathway).
being present in separate neurons from those expressing
D2R heteroreceptor complexes (Fuxe et al., 2014e, 2015b;
Borroto-Escuela and Fuxe, 2017) (Figure 1). In certain neuron
populations they may, however, be coexpressed in the same
neurons and form D1R-D2R heteroreceptor complexes These
are coupled to Gq and operate via an intracellular calcium
signaling cascade (George and O’Dowd, 2007). Our results on
CCK-8 modulation of striatal D2Rs in the 1990’s (Li et al.,
1994) can in fact be well-explained by the discrete existence
of D1R-D2R heteromers in striatal membranes. CCK-8 via
CCK2R reduced the affinity of the D2R but upon activation
of D1Rs in the striatal membrane preparation the CCK-
8 actions switched into increasing the affinity of the D2R.
Such a change may reflect the existence of CCK2R-D2R-D1R
trimeric complexes in which D1R receptor activation changes
the allosteric antagonistic CCK2R-D2R interaction into an
enhancing allosteric interaction.
INTEGRATION OF SIGNALS IN
NIGRO-STRIATAL DA TRANSMISSION
THROUGH VARIOUS TYPES OF DA
RECEPTORS AND THEIR
HETERORECEPTOR COMPLEXES
The average nigro-striatal DA neuron possessed large numbers
of axonal nerve terminals with a calculated total length of
55 to 77 cm, and found to form widely spread and highly
dense axonal arborizations over the neostriatum (Anden et al.,
1966; Matsuda et al., 2009). DA is released to diffuse via
short-distance volume transmission and activate especially
extrasynaptic and synaptic dopamine heteroreceptor complexes
of glutamate synapses on the striato-pallidal GABA pathway and
the striato-entopeduncular/nigral GABA pathway (Figure 1).
Thus, each DA neuron can modulate the glutamate synapses of
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FIGURE 2 | Illustration of how dopamine (DA) released from one DA varicosity via extrasynaptic volume transmission can reach in the same time-frame both the D4Rs
on the striosome GABA neurons directly innervating the nigral DA neurons and D1Rs of the striato-entopeduncular/nigral GABA pathway. To the left is shown the
enrichment of D4Rs in the striosomes of the caudate putamen (CPU). The D4R is known to form a significant D4R-MOR heteroreceptor complex in the striosomes,
shown as a heterodimer in balance with D4R and MOR homoreceptor complexes shown as heterodimers. The D4R protomer enhances the affinity of the MOR
protomers which leads to enhanced MOR signaling of the D4R-MOR heteroreceptor complex increasing its inhibition of the striosome GABA neurons. As a result
disinhibition of the nigro-striatal DA neurons takes place with enhancement of movements. This action may be further increased by the activation in the same time
frame of the D1Rs belonging to D1R homo-heteroreceptor complexes of the direct pathway. On the other hand, the activation of the D1Rs on the striosomes should
enhance their activity, which may avoid excessive activation the nigro-striatal DA neurons.
the indirect GABA pathway, enriched in D2Rs and producing
motor inhibition. At the same time it can modulate the direct
GABA pathway, enriched in D1Rs and causing motor initiation
(Fuxe and Borroto-Escuela, 2015) (Figure 1). In the various
regions of the DA terminal network of each DA neuron, DA
released can modulate via volume transmission different types
of DA heteroreceptor complexes with differential effects on
the signaling of the glutamate synapses and their extrasynaptic
regions on these two efferent GABA pathways. Some DA neurons
may mainly modulate the glutamate synapses on the direct
pathway and while others may mainly modulate the indirect
pathway with consequences for sensory-motor integration and
movements (Figure 1).
In the DA transmission process cholinergic interneurons
with D2R and D5R and GABA interneurons with D5Rs (Yan
and Surmeier, 1997; Rivera et al., 2002a) may also become
modulated (Figure 3). DA heteroreceptor complexes have not
yet been identified in the striatal interneurons. However, in a
pioneering paper (Liu et al., 2000) D5R-GABAA heteroreceptor
complexes were demonstrated in hippocampal neurons through
interactions between the C-terminal of the D5R and the
intracellular loop2 of the short gamma2 subunit of the GABAA
receptor. Through allosteric receptor-receptor interactions the
D5R activation diminished the GABAA alpha1beta2gamma2
receptor induced miniature postsynaptic ion currents. It seems
possible that D5R-GABAA heteroreceptor complexes can also
exist on the striatal interneurons (Rivera et al., 2002a). Thus, via
short distance volume transmission in the um range at least some
nigro-striatal DA neuronsmay alsomodulate the GABA synapses
and their extrasynaptic regions on the striatal interneurons
to various degrees with a possible preferential modulation of
e.g., cholinergic interneurons, parvalbumin positive fast spiking
GABA interneurons and NPY positive GABA interneurons with
low threshold spiking (Figure 3).
The postulated D5R-GABAA heteroreceptor complexes on
the striatal interneurons may also be of relevance for modulating
the recurrent collateral GABA transmission of the D2R positive
indirect andD1R positive direct GABA pathways onto the striatal
interneurons (Figure 3).
At least some nigro-striatal DA neurons also send collaterals
into the striosome/island compartment of the dorsal striatum
(Fuxe et al., 1974) built up of GABA neurons projecting
directly onto nigral DA nerve cells, mainly their dendrite
regions, producing a special architecture of the GABA terminals
on the DA dendrites (Crittenden et al., 2016) (Figure 2).
The D4R is found in high densities in the striosomes/islands
but also exist in reduced densities in the striato-pallidal and
striato-entopeduncular/nigral efferent GABA pathways mainly
in a prejunctional position on the glutamate terminals (Rivera
et al., 2002b). The major DA receptor in the striosomes is
the D4R together with the D1R subtype. The D4R is mainly
located in dendritic shafts and spines of the striosomes/islands
and its activation in this compartment can help mediate the
limbic behaviors induced by D4Rs. A putative D4R-MOR
heteroreceptor complex exists in the striosomes/islands with
enhanced receptor-receptor interactions leading to enhanced
inhibitory MOR signaling in this striatal compartment (Rivera
et al., 2017) (Figure 2). This interaction assists in enhancing the
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FIGURE 3 | Illustration of how dopamine (DA) release from DA varicosities can activate via volume transmission the D5Rs of the striatal GABA interneurons. Putative
D5R-GABAA heteroreceptor complexes may exist on the striatal GABA interneurons in which the D5R protomer inhibits the GABAA signaling. As a result the GABAA
receptor signaling of the GABA interneurons can become reduced. Due to this inhibition of GABAA receptor signaling the activity of the GABA interneurons will
become enhanced, which may lead to a reduced activity in the GABA projection neurons.
morphine induced activation of the nigro-striatal DA pathway
(Rivera et al., 2017).
It is therefore of relevance that the activation of at least
certain nigro-striatal DA neurons can involve an activation of
the D4R and D1R in the striosomal compartment through
short distance extrasynaptic volume transmission. Thus, this
integrative mechanism may provide a feed-back to increase
neuronal activity in the nigro-striatal DA pathway.
It becomes possible to understand how combinations
of individual nigro-striatal DA neurons via the five DA
receptor subtypes and their heteroreceptor complexes can
create large numbers of functional states. It gives us a rich
repertoire of movements. This ability may rest on the capacity
of the individual nigro-striatal DA neuron to modulate
via DA volume transmission both the direct and indirect
GABA efferent pathways (Figure 1), the striosome/island
GABA pathways (Figure 2) and/or the cholinergic and
GABAergic interneurons (Figure 3). These DA modulations
may be dynamic and state dependent which remains to be
discovery.
DA MODULATION OF THE GLUTAMATE





This receptor complex was identified in 2006 (Liu et al., 2006)
in postsynaptic densities by means of co-immunoprecipitation.
The receptor interface involves the C-terminal of the D2R
and the GluN2B subunit. It is proposed that DA via short
distance volume transmission can diffuse to reach and activate
both extrasynaptic and synaptic D2R protomers in D2R-
NMDAR complexes. The allosteric mechanism involved a
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D2R mediated reduction of the NMDAR currents through
a reduced binding of CaMKII to the GluN2B leading to a
reduced phosphorylation of this subunit and reduced current
flow through the NMDAR channels (Liu et al., 2006). The
analysis was performed on medium-sized striatal neurons
in vivo.
Further electrophysiological work on corticostriatal synaptic
glutamate transmission onto striatopallidal GABA neurons
in combination with 2-photon imaging demonstrated that
D2R activation could reduce synaptic glutamate transmission
without changing the currents through glutamate receptor
channels (Higley and Sabatini, 2010). Instead the D2R
mediated inhibition involved a selective reduction of
calcium influx over the NMDAR channels as well as over
the R type voltage gated calcium channels. This inhibitory
D2R action on NMDARs was dependent on inhibition
of PKA activity and counteracted by A2AR co-activation.
These significant results indicate the possibility that D2R
induced inhibition of PKA mediated phosphorylation of
the NMDAR protomer in D2R-NMDAR heteroreceptor
complex plays a role in the allosteric receptor-receptor
interactions.
The synaptic plasticity induced by D2R activation in the
glutamate synapse may lead to a switch from NMDAR–
dependent long term potentiation to NMDAR dependent long
term depression (Higley and Sabatini, 2010). The D2R agonist
induced inhibition of glutamate release also plays a role in these
events see Wang et al. (2012) with the D2R putting a brake
on the signaling of the N type calcium channels with which
it forms a receptor-protein complex (Kisilevsky and Zamponi,
2008).
It is also possible that D2-like receptors transactivate a
receptor tyrosine kinase (RTK) inhibiting the NMDAR function
as demonstrated in hippocampal pyramidal neurons (Kotecha
et al., 2002). The existence of RTK-GPCR heteroreceptor
complexes was proposed in 2007 (Fuxe et al., 2007b) and one
year later the existence of a FGFR1-A2AR and FGFR1-5-HT1A
heteromers were demonstrated for the first time (Flajolet et al.,
2008; Borroto-Escuela et al., 2012b, 2013b). Thus, it seems
likely that also D2R-RTK-NMDAR heteroreceptor complexes
can exist in the synaptic and/or extrasynaptic membranes of the
striato-pallidal GABA neurons.
Relevance for Parkinson’s Disease
The motor inhibition mediated by the striato-pallidal GABA
pathway is weakened through the D2R induced reduction of the
glutamate drive. The anti-parkinson actions of D2R agonists can
therefore be in part mediated by an action at the D2R-NMDAR
heteroreceptor complex. It will therefore be of interest to test the
anti-parkinson actions of heterobivalent compounds built up of
D2R agonist and GluN2B antagonist pharmacophors. In this way
it may be possible to specifically target this receptor complex and
reduce activity in the striato-pallidal GABA pathway. However, it
is unknown howmany of the glutamate synapses on this pathway
contains the D2R-NMDAR heteroreceptor complexes and brain
penetrance of such large heterobivalent compounds may be a
problem (Navarro et al., 2016).
A2AR-D2R Heteroreceptor Complexes
DA released from the nigrostriatal DA neurons onto striato-
pallidal GABA neurons, via short distance volume transmission
target the D2R protomers located in vicinity of A2AR at
the postsynaptic level and having mainly an extrasynaptic
location giving rise to A2AR-D2R heteroreceptor complexes
(Hillion et al., 2002; Canals et al., 2003; Fuxe et al., 2005,
2010b; Borroto-Escuela et al., 2010b,c, 2011b, 2017c; Feltmann
et al., 2018) (Figure 1). These receptor complexes exhibited
allosteric antagonistic A2AR-D2R interactions with the A2AR
reducing the affinity of the high affinity D2R agonist binding
sites (Ferre et al., 1991; Fuxe et al., 1993, 1998). The A2AR
protomer also counteracted the Gi/o mediated signaling of
the D2R with loss of inhibition of the AC-PKA pathway
(Borroto-Escuela et al., 2010b) and of the reduction of
the L-type calcium currents and of excitability over the
PLC beta-IP3-calcineurin signaling pathway (Hernandez-Lopez
et al., 2000). As a result an increased activity developed
in the striatopallidal GABA pathway with enhanced motor
inhibition.
With proximity ligation assay the A2AR-D2R heteroreceptor
complexes were found all over the dorsal striatum (Trifilieff
et al., 2011; Borroto-Escuela et al., 2013d). It seems likely that
they exist mainly extrasynaptically to glutamate synapses which
in their postsynaptic membrane can contain D2R-NMDAR
heteroreceptor complexes. The A2AR is activated by its ligand
adenosine which is formed in the extracellular space from ATP,
released from neurons and astroglia, by means of cell surface
ectonucleotidases (Navarro et al., 2016).
Relevance for Parkinson’s Disease
Parkinson’s disease DA volume transmission becomes
progressively reduced and adenosine activation of the A2AR
will put an increasingly stronger brake on the D2R signaling in
the receptor complex, since the D2R protomer is not properly
activated. For this reason the adenosine A2AR antagonists were
introduced for treatment of Parkinson’s disease (Fuxe et al.,
1970b, 1993; Fuxe and Ungerstedt, 1974; Ferre et al., 1991).
One of them, namely istradefylline, reached the clinic in Japan
showing an ability to increase the anti-parkinson actions of
levodopa including an improvement of the wearing off of the
levodopa action (Dungo and Deeks, 2013). It was proposed that
the early treatment with A2AR antagonists is of importance
to prevent the reorganization of the DA heteroreceptor
complexes into a dominance of A2AR-D2R heteroreceptor
complexes (Fuxe et al., 2015b; Borroto-Escuela and Fuxe, 2017).
A2AR antagonists may also have neuroprotective actions by
blocking A2ARs, including those on the microglia which may
counteract neuroinflammation (Schwarzschild et al., 2006).
Also the development of heterobivalent compounds with A2AR
antagonist and D2R agonist pharmacophors has started but so
far with limited success (Soriano et al., 2009).
It should be realized that the A2AR antagonists will likely
not improve the function of the D2R protomer inhibiting
the NMDAR protomer signaling of the synaptic D2R-NMDAR
heterorecceptor complex involving the GluN2B subunit in the
striato-pallidal GABA neurons. This may be true also for other
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D2R containing heteroreceptor complexes. Therefore, combined
treatment with A2AR antagonists and D2R agonists may be
preferred in bringing down a dominant glutamate transmission
in this pathway mediating motor inhibition. In this way the
function of all D2R can be enhanced whether they operate




Likely also A2AR-D2R-mGluR5 heteroreceptor complexes exist
andmainly in the extrasynaptic regions of the glutamate synapses
on the dorsal striato-pallidal GABA neurons (Ferre et al., 2002;
Fuxe et al., 2003a, 2008b; Cabello et al., 2009; Ciruela et al.,
2011). It is of interest that coactivation of the A2AR and mGluR5
protomers leads to enhanced inhibition of the D2R protomer
recognition and Gi/o mediated signaling onto the AC-PKA-
CREB and MAPK pathways (Fuxe et al., 2001; Popoli et al.,
2001; Ferre et al., 2002). The behavioral results also show that
especially cotreatment with A2AR and mGluR5 antagonists
produce antiparkinsonan actions (Schwarzschild et al., 2006).
Synaptic glutamate reaches the extrasynaptic mGluR5
protomer of the trimeric heteroreceptor complex via
extrasynaptic volume transmission. However, also astroglia
is an important source of glutamate and activates the mGluR5
of this receptor complex via glial volume transmission. The
adenosine volume transmission signal originates from ATP
released from glutamate synapses and astroglia and is broken
down by cell surface ectonucleotidases into adenosine located
in the extracellular space to activate the A2AR protomer of
this receptor complex (Fuxe et al., 2007c; Navarro et al., 2016).
Adenosine is a major modulator suppressing arousal and
enhancing sleep, involving activation of the A2AR protomer of
this heterotrimeric complex.
It is of substantial interest that this extrasynaptic A2AR-D2R-
mGluR5 heteroreceptor complex on the surface membrane of the
striato-pallidal GABA neurons, which inhibit movements, can
integrate glutamate, adenosine and DA signals from glutamate
synapses, astroglia and DA terminals. The aim of this integration
may be to assist in having a balance between motor demands
induced by DA on the D2R and motor inhibition induced
by synaptic and extrasynaptic glutamate volume transmission
and glutamate and adenosine astroglial volume transmission.
In agreement, dual-probe microdialysis demonstrated that the
A2AR and the mGluR5 synergistically inhibit the signaling of the
D2R on the dorsal striato-pallidal GABA pathway (Beggiato et al.,
2016). Thus, integration of A2AR, mGluR5 and D2R signaling
may also take place in vivo in the living brain.
Relevance for Parkinson’s Disease
In Parkinson’s disease the striatal DA nerve terminal networks
progressively degenerate with reduced activation of the striatal
D2R complexes in a number of D2R homo-heteroreceptor
complexes. Enhanced release of glutamate and ATP in glutamate
synapses will develop with increased volume transmission
and activation especially of extrasynaptic A2AR and mGluR5,
which may increase the formation of A2AR-D2R and A2AR-
D2R-mGluR5 heteroreceptor complexes. Thus, in Parkinson’s
disease a reorganization can develop with a dominance
of D2R heteroreceptor complexes in which A2AR and/or
mGluR5 protomers produces a brake on D2R signaling.
It seems possible that early treatment with A2AR and/or
mGluR5 antagonists can help stop this reorganization of the
receptor panorama and counteract the wearing off of the
antiparkinsonian effects of levodopa and D2R agonists and delay




DA released from the dorsal striatal DA terminals also reaches
via short distance volume transmission D2R protomers of
D2R-neurotensin receptor subtype 1 (NTS1R) heteroreceptor
complexes demonstrated with coimmunoprecpitation and BRET
(Koschatzky et al., 2011; Borroto-Escuela et al., 2013c). They
are probably mainly located extrasynaptically on the cortico-
striatal glutamate terminals innervating the dorsal striato-pallidal
GABA neurons (Herve et al., 1986; Boudin et al., 1996) and
on the nigro-striatal DA nerve terminals involving the D2R
autoreceptor (Boudin et al., 1996; Alexander and Leeman, 1998).
Only a low density exists on the striato-pallidal GABA neurons
(see also Ferraro et al., 2014). The in situ proximity ligation assay
analysis still remains to be performed on the existence of these
receptor complexes in these different compartments.
The antagonistic allosteric NTS1R-D2R interactions in these
receptor complexes were already demonstrated in the ventral and
dorsal striatum in the 1980’s in biochemical binding experiments
(Agnati et al., 1983; Von Euler and Fuxe, 1987; von Euler et al.,
1991; Fuxe et al., 1992a). Stronger reductions of the D2R high
affinity agonist binding sites by NT peptides were observed
with receptor autoradiography (Li et al., 1993, 1995). The
antagonistic receptor-receptor interaction on D2R binding by
NTS1R activation was blocked by a NTS1R antagonist SR48692
(Diaz-Cabiale et al., 2002). In line with these results it was
possible in CREB gene reporter gene assays in cell lines to show
that the NTS1R agonist JMV 449 reduced the Gi/o mediated
signaling of the D2R (Borroto-Escuela et al., 2013c). Instead
the NTS1R agonist and the D2R agonist synergized to increase
MAPK activity probably due to enhancement of PKC activity in
the intracellular cascades (Borroto-Escuela et al., 2013c).
Through microdialysis studies with measurements of
extracellular levels of striatal DA, evidence was obtained for
the existence of antagonistic NTS1R-D2 receptor-receptor
interactions in striatal DA nerve terminals involving the D2R
autoreceptors (Tanganelli et al., 1989; Ferraro et al., 1997). Thus,
the level of activity of the NTS1R in these receptor complexes can
regulate the ability of the D2R autoreceptor to inhibit DA release.
Thus, high extracellular levels of NT peptides will bring down
D2R autoreceptor functions in the DA terminals and increased
release of DA will develop. As a result dopamine produces
increased D1R activity, known to be located on neurons of the
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direct pathway, leading to enhanced activity of this pathway with
increased initiation of movements (Fuxe et al., 1992b).
This NTS1R-D2R autoreceptor complex also appears to exist
at the level of the nigral DA cell bodies, where NT may diminish
the D2R autoreceptor function as seen from the reduced ability
of the D2R agonist to bring down the firing rate of the DA nerve
cells under the influence of NT (Shi and Bunney, 1990, 1991;
Antonelli et al., 2007a). Other mechanisms can also be involved
like the ability of NTS1R to increase the internalization of the
D2R autoreceptor dependent on the increase in PKC activity
induced by NTS1 activation (Thibault et al., 2011).
It is of high interest that microdialysis studies indicated the
existence of antagonistic NTS1R-D2R interactions at the striatal
glutamate terminal, enhancing glutamate release (Antonelli et al.,
2007a). It was inter alia found that NT counteracts the D2R
agonist induced reduction of potassium evoked striatal glutamate
release (Antonelli et al., 2007b; Ferraro et al., 2014). Other
microdialysis results also indicated the existence of antagonistic
NTS1R-D2R interactions on the striato-pallidal GABA neurons
themselves based on findings that NT counteracted the ability
of D2R agonists to inhibit the striatal and pallidal GABA release
(Ferraro et al., 1997, 1998).
Relevance for Parkinson’s Disease
Using dual-probe microdialysis in hemiparkinson rats it could be
established that the antagonistic NTS1R-D2R receptor-receptor
interactions remained in the dorsal striatum on the lesioned side
with 6-OH-DA microinjections made into the substantia nigra
(Ferraro et al., 2012). The intrastriatal NT injection produced a
counteraction of the DA receptor agonist induced reductions of
pallidal GABA and glutamate extracellular levels. These effects
of NT were blocked by a NT receptor antagonist SR48692,
again given intrastriatally, in line with its antiparkinson actions
(Ferraro et al., 2012; Tanganelli et al., 2012). One significant
target for the antiparkinson actions of NT receptor antagonists
appears to be the NTS1R-D2R heteroreceptor complexes on
the glutamate nerve terminals forming synapses on the striato-
pallidal GABA neurons. By removing the brake on the D2
receptor signaling, an increased inhibition of glutamate release
develops with reduced activation of the indirect pathway
leading to reduced motor inhibition. Combined treatment with
NTS1 and A2A receptor antagonists in Parkinson’s disease
should therefore lead to enhanced antiparkinson actions, since
A2A receptor antagonists instead mainly target the A2AR-
D2R heteroreceptor complexes. They are mainly located in the
dendritic spines of the indirect pathway to remove the A2AR
protomer induced inhibition of the D2R protomers.
Understanding the Integration of D2R
Heteroreceptor Complexes in Dorsal
Striato-Pallidal GABA Neurons
Taken together, the results indicate that the D2R-NMDAR,
A2AR-D2R, and NTS1R-D2R heteroreceptor complexes are all
located on the dorsal striato-pallidal GABA neurons, mediating
motor inhibition, mainly located on the dendritic spines in
relation to or within cortico-striatal glutamate synapses. It is
proposed that they can be located in relation to different
glutamate synapses. However, it is also possible that two or three
of them can modulate the same glutamate synapse since they can
exist at different locations in relation to the same synapse.
The D2R-NMDAR heteroreceptor complex may mainly have
a postsynaptic location within the glutamate synapse itself while
the A2AR-D2R heteroreceptor complex may mainly have an
extrasynaptic location at the postsynaptic level.
Thus, DA transmission from the nigro-striatal DA neuron can
via volume transmission modulate the same glutamate synapse
on the dorsal striato-pallidal GABA neuron via D2R protomers
belonging to two different D2R heteroreceptor complexes,
namely the D2R-NMDAR and A2AR-D2R heteroreceptor
complexes (Liu et al., 2006; Fuxe et al., 2007a). Both of them
operate via antagonistic receptor-receptor interactions with the
D2R protomer inhibiting NMDAR signaling and thus synaptic
glutamate signaling via the NMDAR. Instead the extrasynaptic
D2R protomer is restrained in its activity by the A2AR when
activated by adenosine.
There is the indication that the NTS1R-D2R heteroreceptor
complex is mainly located in an extrasynaptic position
presynaptically on the glutamate nerve terminals besides
being located on the DA nerve terminal membrane forming a
receptor complex with the D2R autoreceptor (Tanganelli et al.,
2012; Ferraro et al., 2014). Therefore, it seems possible that
NTS1R-D2R, A2AR-D2R, and D2R-NMDAR heteroreceptor
complexes can sometimes modulate the same glutamate synapse.
One D2R protomer, located in the synapse, mainly modulates
synaptic NMDAR signaling; the second D2R protomer,
restrained by its A2A protomer, is located extrasynaptically
and modulates the G alpha i/o inhibition of the AC-PKA
pathway and modulates via Gbetagamma dimers activation of
PLC to close the Cav 1.3 calcium channels through activation
of calcineurin leading to dephosphorylation of the calcium
channel; the third D2R protomer is located extrasynaptically on
the glutamate nerve terminal, mainly restrained by its NTS1R
protomer, and inhibits glutamate release. It gives a new view
of how modulation of a single glutamate synapse may involve
multiple D2R heteroreceptor complexes located in different
synaptic and extrasynaptic positions at the nerve terminal and
dendritic level.





DA released from the dorsal striatal DA nerve terminals may in
the same time period not only reach the D2Rs on the striato-
pallidal GABA neurons via extrasynaptic volume transmission
but also the D1R receptors on the striato-entopeduncular/nigral
GABA pathway, the direct pathway (Figure 1). This pathway is
known to initiate movements and early work demonstrated that
D1Rs via the AC-PKA-DARPP-32 and increases in intracellular
calcium levels can enhance striatal NMDAR signaling in the
direct pathway (Cepeda et al., 1993, 1998; Blank et al., 1997). The
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mechanism involved enhanced phosphorylation of the NMDAR
ion channels. With the discovery of the D1R heteroreceptor
complexes and their allosteric receptor-receptor interactions new
mechanisms for the modulation of the direct pathway appeared
(Fuxe et al., 1998, 2008a,b; Gines et al., 2000; Lee et al., 2002;
Franco et al., 2007; Wang et al., 2012). It should be noted that
one nigro-striatal DA neuron can in the same time range enhance
activity in the direct pathway via D1R and reduce activity in
the indirect pathway via D2R to produce movements with an
appropriate reduction of motor inhibition through a reduction of
activity in the dorsal striato-pallidal GABA pathway via the D2R.
Thus, there is a balanced interplay between motor initiation and
removal of motor inhibition.
We will now discuss the role of some of the striatal synaptic
and extrasynaptic D1R heteroreceptor complexes in mediating
DA volume transmission onto the cortico-striatal glutamate
synapses of the direct pathway.
D1R-NMDAR Heteroreceptor Complexes
Fang Liu and colleagues discovered the D1R-NMDAR
heteroreceptor complexes in 2002 (Lee et al., 2002). One
region of the C terminal of the D1R could interact through
a direct receptor-receptor interaction with the NR1 subunit
and another domain of the C-terminal interact with the NR2A
subunit. The following year heteromerization between D1Rs
and NMDARs were indicated to take place in postsynasptic
densities of striatal neurons (Fiorentini et al., 2003). Thus, the
D1R-NMDAR heteroreceptor complex may be mainly present
in postsynaptic membranes of the striato-entopeduncular/nigral
neurons.
The D1R-NR1 interaction may enhance the presence of the
D1R in the plasma membrane providing a mechanism for
upregulating D1R function (Pei et al., 2004). It is unknown
to which extent there exist two types of D1R-NMDAR
heteroreceptor complexes one with the D1R-NR1 interface and
one with the D1R-NR2A interface in balance with each other.
Early on it was found that the D1R-NR1 interaction may
be involved in reducing excitotoxicity mediated by NMDARs
which can involve the activation of a phosphatidylinositol kinase
dependent pathway (Lee et al., 2002).
The uncoupling of the D1R-NMDAR complex with a TAT
peptide (from the transactivator of transcription of human
immunodeficiency virus)–fusion interface interacting peptide
at the D1R-NR1 interface indicated the important role of
this synaptic complex in learning and memory involving an
NR1-CaMKII coupling (Nai et al., 2010). An inhibition of
NMDAR dependent LTP was observed together with reductions
of working memory.
In contrast, the D1R-NR2A direct interaction has an
inhibitory impact on the NMDAR signaling by reducing the ion
flow over the ligand gated ion channels of the NMDARs (Lee
et al., 2002). The mechanism appears to involve a diminished
recruitment of the NMDARs to the plasma membrane. It was
proposed that such events may represent a molecular brake
needed to avoid overactivity of NMDAR signaling (Wang et al.,
2012).
The allosteric receptor-receptor interactions in the D1R-
NMDAR heteroreceptor complexes together with D1R
mediated increases in NMDAR subunit phosphorylation
via the intracellular cascades leads to the enhancement of
D1R-NMDAR heteroreceptor complexes signaling. These
events contribute to increases in the activity over the direct
pathway favoring initiation of movements. Thus, movements
may be enhanced by striatal DA release from nigro-striatal DA
neurons, which via DA volume transmission may diffuse in
parallel from DA terminals into both the glutamate synapses
on the striato-entopeduncular/nigral GABA pathways and
those of the striato-pallidal GABA pathways. The activation
of the D1R protomers will inter alia enhance the synaptic
NMDAR protomer mediated signaling in the direct pathway
while the D2R protomer signaling will inter alia reduce the
synaptic NMDAR protomer signaling in the indirect pathway.
These parallel events may help clarify the crucial role of the
nigro-striatal DA neurons in movements, which may need
a D1R mediated activation of the direct pathway to initiate
movements and a D2R mediated inhibition of the indirect
pathway to reduce motor inhibition. The molecular mechanisms
involve short distance DA volume transmission, and allosteric
receptor-receptor interactions in synaptic D1R-NMDAR and
D2R-NMDAR heteroreceptor complexes in the direct and
indirect GABA pathways, respectively.
Relevance for Parkinson’s Disease
In Parkinson’s disease the D1R agonists will mainly act to
facilitate the initiation of movements since they mainly exist on
the direct pathway. Based on the work of Fang Liu and her group
NR1 agonists should be beneficial for treatment of Parkinson’s
disease, especially when combined with D1R agonists in order to
more effectively activate the direct pathway. Again heterobivalent
compounds should be considered in this case containing D1R
and NR1 pharmacophors.
A1R-D1R Heteroreceptor Complexes
In the 1990ies antagonistic A1R-D1R receptor-receptor
interactions were demonstrated in behavioral and microdialysis
studies (Ferre et al., 1994; Popoli et al., 1996; Fuxe et al., 1998;
Rimondini et al., 1998). The interactions also involved an
inhibition of D1R agonist induced oral dyskinesia in the rabbit
by A1R agonists (Ferre et al., 1994). Biochemical binding studies
on membrane preparations in stably cotransfected fibroblast cells
revealed an uncoupling of the D1R from its G protein. There was
a reduction of the proportion of the D1Rs in the high affinity
state (Ferre et al., 1998; Torvinen et al., 2002). The high-affinity
state of the A1R was found of importance for the antagonistic
A1R induced modulation of D1R recognition and signaling as
studied in stably cotransfected cell lines (Torvinen et al., 2002).
Indications for the existence of A1R-D1R heteroreceptor
complexes were obtained in 2000 through use of
coimmunoprecipitation performed in cotransfected fibroblasts
(Gines et al., 2000), which was validated with BRET/FRET
(Franco et al., 2007). It is of substantial interest that the A1R
activation can counteract the D1R agonist induced disappearance
of the A1R-D1R heteroreceptor complexes (Gines et al., 2000).
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Such actions of A1R agonists may also develop in the caudate
putamen of Parkinson patients. If so, A1R agonists should
contribute to counteracting levodopa induced dyskinesia.
The A1R-D1R heteroreceptor complexes may mainly be
localized to extrasynaptic membrane domains at the postsynaptic
level of glutamate synapses on the striato-entopeduncular/nigral
GABA pathway (direct pathway). It provides a brake on the D1R
signaling and may reduce the development of D1R sensitization
in response to the progressive disappearance of extracellular DA
levels. It is proposed that the A1R-D1R heteroreceptor complexes
reorganize in response to the progressive disappearance of the
DA nerve terminals. The reduced activation of the D1R
may reduce the D1R homoreceptor complexes in balance
with the A1R-D1R heteroreceptor complexes and A1R
homoreceptor complexes. Thus, in Parkinson patients the
A1R-D1R heteroreceptor complexes with antagonistic receptor-
receptor interactions could become dominant with an increased
brake on D1R signaling. As a result the direct pathway becomes
less activated with a reduction of movement initiation. As
discussed, a similar reorganization could take place in the
A2AR-D2R heteroreceptor complexes in the striato-pallidal
GABA pathways inhibiting movements due to a dominance
of A2AR-D2R heteroreceptor complexes with antagonistic
receptor-receptor interactions leading to enhanced motor
inhibition.
Relevance for Parkinson’s Disease
The reorganization of the receptor panorama in the direct
and indirect pathways involving increased formation of A1R-
D1R and A2AR-D2R heteroreceptor pathways, respectively
could contribute to the reduction of movements in Parkinson
disease. Such a mechanism could explain the enhancement
of antiparkinson actions we observed with DA receptor
agonists and levodopa through combined treatment with the
methylxanthine drugs caffeine and theophyllamine already in
1974 (Fuxe and Ungerstedt, 1974).
It is also proposed that the dyskinesias that develop upon
chronic treatment with levodopa may in part be related to a more
marked disruption of the A1R-D1R heteroreceptor complexes
in the direct pathway than of the A2AR-D2R heteroreceptor
complexes in the indirect pathway. As a consequence an
increased formation of D1R homoreceptor complexes can occur
leading to a sensitized D1R mediated DA transmission in
the direct pathway. Thus, an increase in the activity of the
direct pathway enhancing movements takes place which cannot
be matched by a similar reduction of the activity of the
indirect pathway mediating motor inhibition. Such a disbalance
at the network level could contribute to the dyskinesias
observed. A1R agonists should therefore be developed for
treatment of levodopa induced dyskinsesias together with
heterobivalent drugs containing A1R agonist and D1R antagonist
pharmcophors.
D1R-D3R Heteroreceptor Complexes
The D1R-D3R heteroreceptor complexes were first
observed in mammalian cells using BRET and through
coimmunoprecipitation in striatal protein preparations
(Fiorentini et al., 2003, 2008; Marcellino et al., 2008b).
Allosteric receptor-receptor interactions developed in the
receptor complexes since in membrane preparations from
cells and striatum, D3R activation enhanced the affinity of
the D1Rs (Marcellino et al., 2008b) indicating the existence of
synergistic D1R-D3R interactions. They are located mainly in
the extrasynaptic regions of the dendritic spines of the direct
pathway. Behavioral experiments in reserpinized mice supported
the biochemical results since agonist-induced D3R activation
enhanced the D1R agonist induced behavioral actions. Increased
D3R expression potentially linked to D1R can also contribute to
behavioral sensitization to nicotine in view of the DA releasing
action of nicotine (Le Foll et al., 2003). It therefore seems likely
that D3R activation can contribute to D1R induced dyskinesias
through its enhancement of D1R protomer signaling of D1R-
D3R heteroreceptor complexes in the direct pathway (Fuxe
et al., 2008a, 2015b).It disturbs the balance between movement
enhancement (direct pathway) and motor inhibition (indirect
pathway). In line with this view normalizing the D3R function
was found to diminish levodopa induced dyskinesia (Bezard
et al., 2003; Fuxe et al., 2015b).
Relevance for Parkinson’s Disease
The results indicate that increases of D1R-D3R heteroreceptor
complexes linked to the glutamate synapses of the direct
pathway in Parkinson’s disease can contribute to the development
levodopa and D1 receptor agonist induced motor sensitization
and dyskinesias in view of the exaggerated D1R signaling
obtained. D3R antagonists were already suggested to be anti-
dyskinetic drugs in 2002–2003 (Fuxe et al., 2008c). It is here
proposed that they should be combined with A1R agonists in
view of the antagonistic A1R-D1R interactions (Fuxe et al.,
2015b). Also the synthesis of heterobivalent drugs with D3R
antagonist and A1R agonist pharmacophors is warrented for
treatment of levodopa induced dyskinesias.
DA MODULATION OF THE
ISLAND/STRIOSOME COMPARTMENT OF
THE DORSAL STRIATUM INVOLVING
D4R-MOR HETERORECEPTOR
COMPLEXES
In the beginning of the 1970’s the striatum was found to
contain two compartments, the island/striosome and the matrix
compartments through the observations that DA nerve terminals
can form striatal islands of DA nerve terminals with strong
DA fluorescence in the postnatal and adult rat brain (Olson
et al., 1972; Tennyson et al., 1972; Fuxe and Ungerstedt, 1976).
They could later on also be identified with acetylcholinesterase
staining and met-enkephalin-like immunoreactivity and the
islands were given the name striosomes (Graybiel and Ragsdale,
1978; Graybiel and Chesselet, 1984; Graybiel, 1990). In 1988
we identified together with Greengard’s group a complex
architecture of tyrosine hydroxylase, encephalin, and dopamine
and cyclic AMP-regulated phosphoprotein (DARPP-32) like
immunoreactive patches/islands with partial overlaps in
Frontiers in Synaptic Neuroscience | www.frontiersin.org 14 July 2018 | Volume 10 | Article 20
Borroto-Escuela et al. Dopamine Transmission and Plasticity
the dorsal striatum (Agnati et al., 1988). Computer-assisted
morphometric techniques were employed in this analysis.
Later on in 2011 the GABAergic neurons building up the
striosomes/islands were found through a single neuron tracing
study to project to the nigral DA neurons of the zona compacta
(Fujiyama et al., 2011) sending collaterals into the components of
the indirect pathway and the direct pathway. Using a rabies virus
approach the monosynaptic projection from the striatal islands
to the nigral DA neurons could again be demonstrated (Watabe-
Uchida et al., 2012). Graybiel has pioneered our understanding
of the role of these two compartments and their functional
integration in performing habits, rituals and cognitive activities
(Graybiel, 2008), including habitual drug seeking (Crittenden
and Graybiel, 2011).
In 1978 when DA receptor subtypes were beginning to be
demonstrated, a special type of DA receptor was postulated
to be involved in the modulation of the neostriatal islands
since an ergolene derivative with DA receptor agonist activity
preferentially reduced DA turnover in the neostriatal DA islands
but not in the matrix of the neostriatum (Fuxe et al., 1978a).
In 2002 the islands were found to be enriched in D4Rs (Rivera
et al., 2002b) which were also present in the matrix compartment.
It was therefore of high interest that D4R-MOR heteroreceptor
complexes appeared to exist in the striosomes. with the D4R
increasing the affinity of the MOR protomer (Rivera et al.,
2017). Such an action should enhance the MOR inhibition of
the GABA pathway to the nigral DA neurons and increase
their activity. Nevertheless when a D4R agonist was given
systemically it prevented the nigrostriatal DA pathway activation
by morphine. The explanation was that in the pars reticulata of
the substantia nigra the GABA interneurons projecting to the
nigral DA neurons were modulated by antagonistic receptor-
receptor in D4R-MOR heteroreceptor complexes (Rivera et al.,
2017). This may be due to another composition of these
receptor complexes than those in the striatal islands leading
to antagonistic receptor-receptor interactions in these receptor
complexes in the GABA interneurons and their activation. As
a consequence, morphine induced activation of the nigrostriatal
DA neurons was blocked (Rivera et al., 2017). Thus, in this way
a balanced modulation exists of the nigro-striatal DA neurons by
GABAergic mechansims involving the direct striosomal GABA
pathway and the GABA interneurons. However, a selective
activation of the D4R protomer in the D4R-MOR heteroreceptor
complex of the striatal island/striosome should inhibit the
striosome-nigral GABA pathway to nigro-striatal DA neurons
and contribute to their activation (Figure 2).
Based on the above discussion it seems clear that many of the
nigro-striatal DA neurons will through short distance volume
transmission in the um range not only enhance activity of the
direct pathway and reduce activity in the indirect pathway to
make movements possible but also exert a positive feedback on
the activity of the nigro-striatal DA neurons. Thus, diffusing
DA via especially D4R will in parallel inhibit the activity of
the inhibitory striosome-nigral GABA pathway to the nigral
DA nerve cells. As a result their GABA inhibition becomes
reduced and activity increases in parts of the nigro-striatal DA
pathway. The inhibition of activity involves activation of the
D4R protomer in the striatal island operating via inhibitory Gi/o
mediated signaling, especially in combination with enkephalin
induced activation of the MOR protomer also operating via
Gi/o mediated signaling. As pointed out, the receptor-receptor
interactions in the D4R-MOR heteroreceptor complexes in the
striosomes appear to enhance the inhibitory MOR signaling.
Relevance for Parkinson’s Disease
The enkephalins are released from the dorsal striato-pallidal
GABA neurons. They are enriched in D2Rs, and known to
produce motor inhibition (Steiner and Gerfen, 1998). Increased
activity in the striato-pallidal GABA neurons will therefore
increase the release of enkephalins which via short and long
distance volume transmission can contribute to the inhibition of
the striosome-nigral GABA pathway to the nigral DA cells and
offers a way to enhance activity in the nigro-striatal DA neurons
through disinhibition. In Parkinson’s disease the inhibitory
D4R in the striosomes should have a reduced activation due
to the progressive disappearance of DA volume transmission.
Therefore, it is proposed that also D4R agonists may be
introduced in treatment of Parkinson’s disease that inhibit the
overactivity in the island-nigral GABA pathway to the nigral DA
nerve cells. For specificity reasons it may be important to use
heterobivalent compounds with D4R agonist and MOR agonist
pharmacophors that may preferentially target the D4R-MOR
heteromers of the striosomes.




There are results indicating that A2AR and D2R receptors exist
also on the cholinergic interneurons with antagonistic A2AR-
D2R interactions modulating their activity (Tozzi et al., 2011).
An interesting model was proposed in which the cholinergic
interneurons modulate the activity of both the striato-pallidal
and the striato-entopeduncular/nigral GABA pathways via
muscarinic M1Rs inhibiting the activity of the L-type calcium
channels on these efferent GABA pathways (Tozzi et al., 2011).
The DA activated D2R protomer under inhibitory control by
the A2AR protomer exerted an inhibitory regulation of the
cholinergic interneurons removing the cholinergic activation of
the inhibitory M1Rs and activity in the L-type calcium channels
was restored in the striatal projection neurons. As a result calcium
influx developed with production of endocannabinoids which
acted as retrograde messengers in the glutamate synapses to
reduce via CB1Rs glutamate release and activity in the indirect
GABA pathwaymediatingmotor inhibition and the direct GABA
pathway initiating movements (Tozzi et al., 2007, 2011).
This appears to be an elegant way for the A2AR-D2R
interaction on the cholinergic interneurons to fine tune a
balanced inhibition of the glutamate drive of the indirect and
direct GABA pathways. This may allow an optimal production
of fast vs. slow movements.
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It should also be considered that D2Rs exist on the cortico-
striatal glutamate terminals regulating the glutamate drive of
these two GABA pathways. Furthermore, antagonistic CB1R-
D2R interactions were demonstrated in striatal CB1R-D2R
heteroreceptor complexes (Marcellino et al., 2008a). Thus
excessive inhibition of glutamate release can be avoided. In view
of the evidence that CB1R-D2R-A2AR trimeric heteroreceptor
complexes also exist in cellular models (Carriba et al., 2008)
it is possible that they may exist also on the cortico-striatal
glutamate terminals. With inhibition of the D2R protomer by the
CB1R protomer the activity of the A2AR protomer may be set
free to enhance activity of the N type calcium channels in the
glutamate terminals (Tanganelli et al., 2004). This may further
ensure activity in the corticostriatal glutamate terminals.
It seems clear that the ability of some of the nigro-striatal
DA neurons to modulate via short distance volume transmission
also the cholinergic interneurons through their D2Rs has a
significant impact since it may regulate in parallel and in the
same direction the glutamate drive of both the indirect and direct
GABA pathways.
Relevance for Parkinson’s Disease
In Parkinson’s disease also the inhibitory D2R signaling on
the cholinergic interneurons will become reduced. As a result
the cholinergic interneurons will develop an increased activity
reducing the activity of the direct and indirect GABA pathways
via the activation of their inhibitory M1 receptors. Thus,
antiparkinson actions of D2R agonists also involves an action
at D2Rs of the cholinergic interneurons to bring back activity
in the striatal GABA projection neurons via inhibition of the
cholinergic interneurons.




Rivera and colleagues demonstrated a high expression of
D5Rs in subtypes of striatal GABA interneurons especially
the somatostatin/neuropeptide Y/nitric oxide synthase
immunoreactive or the calcium binding protein parvalbumin
immunoreactive interneurons in addition to the large spiny
cholinergic neurons (Rivera et al., 2002a).
These findings are of high interest, especially in view of the
discovery of Fang Liu and colleagues in 2000 that dopamine D5Rs
form heteroreceptor complexes with GABAA receptors (Liu et al.,
2000). The D5R C-terminal domain physically interacted with
the second intracellular loop of the γ2 receptor subunit of the
GABAA receptor. Specificity it was shown by the fact the D5R
but not the D1R interacted with gamma subunit in hippocampal
neurons and in cotransfected cells. Bidirectional antagonistic
allosteric receptor-receptor interactions were observed with D5R
activation diminishing GABAA α1β2γ2 mediated inhibitory
currents at a postsynaptic location (Liu et al., 2000). Furthermore,
GABAA activation reduced the D5R receptor induced increase in
adenylyl cyclase activity.
Based on this work, it seems possible that D5R-GABAA
heteroreceptor complexes may also exist on the D5R positive
striatal GABA interneurons and cholinergic interneurons. Again
it is proposed that antagonistic allosteric receptor-receptor
interactions may develop in the postulated striatal D5R-GABAA
heteroreceptor complexes with reduction of the disinhibition of
these GABA interneurons by recurrent GABA collaterals from
the direct and indirect GABA efferent pathways. Thus, DA
volume transmission from striatal DA nerve terminal networks
can directly modulate also the striatal GABA interneurons
especially via the D5Rs potentially modulating their activity
also via their postulated D5R-GABAA heteroreceptor complexes
(Figure 3). The existence of such heteroreceptor complexes in the
striatal GABA interneurons remains to be investigated.
CONCLUSIONS
The concept that develops based on the current review is
that DA transmission in the brain mainly takes place through
short distance volume transmission in the µm range with DA
diffusing into extrasynaptic and synaptic regions of glutamate
and GABA synapses. DA transmission is accomplished by
its binding to five different receptor subtypes, D1R to D5R
receptors, and the formation of a network of extrasynaptic
and synaptic DA heteroreceptor complexes. A rich integration
of synaptic and volume transmission signals can take place
in these DA receptor complexes through allosteric receptor-
receptor interactions. Such key integrative processes are made
possible by the fact that both D1R and D2R are hub receptors,
each of them capable of forming heteroreceptor and isoreceptor
complexes with more than ten other types of receptors including
not only GPCRs and ligand gated ion channel receptors but
also receptor tyrosine kinases, adaptor proteins and transporter
proteins (Borroto-Escuela et al., 2014, 2016a).
The concept is also introduced that the major part of the
nigro-striatal DA neurons, each having large numbers of DA
terminals from which DA is released, can through volume
transmission directly influence all the striatal cell types in parallel,
since they possess DA receptors. It involves e.g., the DA D1R and
D2R subtypes located on the GABA nerve cells forming the direct
and the indirect GABA pathways, respectively, the D4R subtype
on the GABA nerve cells forming the island-/striosome GABA
pathway to the DA nigral cells, the D2R and D5R on the striatal
cholinergic neurons and the D5Rs on the GABA interneurons.
These features of the nigro-striatal DA neuron to modulate
in parallel the activity of practically all the striatal nerve cell
types in the dorsal striatum, including also the glial cells (Fuxe
et al., 2015a), through the DA receptor complexes allows us to
understand its unique and crucial fine-tuning of movements,
which is lost in Parkinson’s disease. The fine tuning of the striatal
networks depends significantly on the ability of the individual
nigro-striatal DA neuron to modulate, through its rich network
of terminal varicosities, large numbers of striatal nerve cells
of different kinds in parallell via short distance DA volume
transmission. One example of fine tuning is given by the ability
of the DA volume transmission from a single nigro-striatal DA
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neuron to enhance the activation and motor initiation via D1Rs
on several striato-entopeduncular/nigral GABA neurons and to
reduce in the same time frame activation and motor inhibition
via D2Rs on several striato-pallidal GABA neurons. Thus, the fine
tuning of the striatal networks is also accomplished through the
existence of DA receptor subtypes (D1R–D5R) which can form
heteroreceptor complexes with each other and with large number
of other types of receptors including GPCRs, ligand gated ion
channel receptors and receptor tyrosine receptor kinases. In this
way the striatal glutamate and GABA synapses and the striatal
neurons on which they are located can become fine-tuned in a
dynamic way by dopamine allowing our movements to develop.
These characteristics of the nigro-striatal DA transmission
also makes us understand why levodopa often provides the best
symptomatic treatment in Parkinson’s disease. Thus, the DA
formed can via DA volume transmission activate all the DA
receptor subtypes involved, although without the fine tuning
imposed by the dynamic neuronal firing of each nigro-striatal DA
neuron.
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